Published in Cancer on August 15, 2001
HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol (2010) 6.53
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol (2008) 3.55
Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol (2006) 2.91
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol (2003) 2.26
Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res (2010) 2.11
HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol (2009) 2.08
Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res (2013) 1.87
Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76
A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol (2011) 1.58
Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer (2010) 1.57
Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A (2006) 1.57
The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med (2011) 1.40
Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res (2009) 1.31
Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.25
Head and neck cancer: an evolving treatment paradigm. Cancer (2008) 1.21
Immune suppression in head and neck cancers: a review. Clin Dev Immunol (2011) 1.17
The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol (2013) 1.17
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol (2007) 1.13
Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. Cancer (2009) 1.09
New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital (2013) 1.07
Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol (2009) 1.07
Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Res (2009) 1.06
Human Papilloma Virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital (2009) 1.05
Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol (2009) 1.04
Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest. Cell Cycle (2013) 1.04
Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. Expert Opin Med Diagn (2010) 1.03
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer. Cancer Med (2012) 1.02
Evidence for a causal association for HPV in head and neck cancers. Eur Arch Otorhinolaryngol (2011) 1.01
Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice. Virology (2010) 1.00
Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys (2014) 0.97
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer (2003) 0.95
The relationship between oral squamous cell carcinoma and human papillomavirus: a meta-analysis of a Chinese population (1994-2011). PLoS One (2012) 0.94
Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer. Nat Rev Urol (2011) 0.94
Impact of HPV in Oropharyngeal Cancer. J Oncol (2010) 0.93
Is radiation dose reduction the right answer for HPV-positive head and neck cancer? Oral Oncol (2013) 0.91
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer (2013) 0.91
Human papillomavirus genotype and oropharynx cancer survival in the United States of America. Eur J Cancer (2015) 0.90
Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx. Br J Cancer (2011) 0.89
Lessons learned from next-generation sequencing in head and neck cancer. Head Neck (2012) 0.88
Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland. J Clin Pathol (2007) 0.88
Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer (2008) 0.87
HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital (2014) 0.85
P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein. Virol J (2008) 0.84
Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck. Oncotarget (2015) 0.84
The transcriptional regulator gene E2 of the Human Papillomavirus (HPV) 16 influences the radiosensitivity of cervical keratinocytes. Radiat Oncol (2012) 0.84
Clinical and scientific impact of human papillomavirus on head and neck cancer. World J Clin Oncol (2014) 0.83
Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review. World J Clin Cases (2014) 0.83
Human papillomavirus (HPV) related carcinomas of the upper aerodigestive tract. Head Neck Pathol (2007) 0.83
HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol (2008) 0.83
HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience. Int J Otolaryngol (2013) 0.83
[HPV in non-gynecological tumors]. Pathologe (2008) 0.82
Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial. Cancer (2011) 0.82
Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2010) 0.82
Human papilloma virus infection in head and neck cancer. Dtsch Arztebl Int (2013) 0.81
Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging (2012) 0.81
The impact of virus in N3 node dissection for head and neck cancer. Eur Arch Otorhinolaryngol (2008) 0.80
Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects. Wien Med Wochenschr (2010) 0.80
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. Infect Agent Cancer (2011) 0.79
Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer. BMC Cancer (2013) 0.79
The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model. Cancer Biol Ther (2012) 0.79
Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer. PLoS One (2012) 0.79
Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? Eur Arch Otorhinolaryngol (2015) 0.78
Counseling the patient with potentially HPV-related newly diagnosed head and neck cancer. Curr Oncol Rep (2014) 0.78
Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era. Eur Arch Otorhinolaryngol (2013) 0.78
Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program. Int J Radiat Oncol Biol Phys (2007) 0.78
Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies. J Comput Assist Tomogr (2013) 0.78
HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis (2015) 0.78
Activation of Akt at T308 and S473 in alcohol, tobacco and HPV-induced HNSCC: is there evidence to support a prognostic or diagnostic role? Exp Hematol Oncol (2014) 0.77
Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy. Eur Arch Otorhinolaryngol (2014) 0.77
Valosin-containing protein (VCP/p97)-expression correlates with prognosis of HPV- negative oropharyngeal squamous cell carcinoma (OSCC). PLoS One (2014) 0.77
Update on role of chemotherapy in head and neck squamous cell cancer. Indian J Surg Oncol (2010) 0.77
MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clin Exp Metastasis (2009) 0.77
Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study regarding Tobacco and Alcohol Consumption. Patholog Res Int (2011) 0.77
Clinical features and treatment strategy for HPV-related oropharyngeal cancer. Int J Clin Oncol (2016) 0.77
Chronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis. PLoS One (2015) 0.76
Evaluation of the Prevalence Rate and the Prognostic Effect of Human Papilloma Virus Infection in a Group of Patients With Oral Cavity Squamous Cell Carcinoma. Iran J Cancer Prev (2016) 0.75
De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review. Oncol Lett (2015) 0.75
Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx. J Biomed Res (2010) 0.75
Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment-a Pilot Study from Northern India. Indian J Surg Oncol (2016) 0.75
Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for Therapy. Rare Cancers Ther (2015) 0.75
Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome. Eur J Nucl Med Mol Imaging (2015) 0.75
Recent advances in managing human papillomavirus-positive oropharyngeal tumors. F1000 Med Rep (2010) 0.75
Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial. Adv Radiat Oncol (2016) 0.75
No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression. Eur Arch Otorhinolaryngol (2015) 0.75
Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res (2001) 2.80
Proliferation and turnover of glial cells in the forebrain of young adult mice as studied by repeated injections of 3 H-thymidine over a prolonged period of time. J Comp Neurol (1973) 2.03
Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood (1993) 1.63
MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol (2001) 1.62
Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun (1994) 1.39
Early and enhanced germinal center formation and antibody responses in mice after primary stimulation with antigen-isologous antibody complexes as compared with antigen alone. J Immunol (1971) 1.20
Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol (1992) 1.18
Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue. Gastroenterology (1992) 1.13
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut (1998) 1.09
High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer (1994) 1.05
Immunohistochemical localization of somatostatin receptors sst2A in human tumors. Am J Pathol (1998) 1.04
[Familial analphalipoproteinemia (Tangier disease)]. Schweiz Med Wochenschr (1968) 1.02
Distinctive medullary and germinal center proliferative patterns in mouse lymph nodes after regional primary and secondary stimulation with tetanus toxoid. J Immunol (1974) 1.01
Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci (1994) 0.99
Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation. Int J Cancer (2001) 0.98
Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy. Br J Cancer (2005) 0.94
Retracted Altered regulation of ERK1b by MEK1 and PTP-SL and modified Elk1 phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs. J Biol Chem (2001) 0.93
New irradiation geometry for microbeam radiation therapy. Phys Med Biol (2005) 0.92
Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment. Int J Gynecol Cancer (2005) 0.92
Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance. Yale J Biol Med (1999) 0.90
Establishing radiological percutaneous gastrostomy with balloon-retained tubes as an alternative to endoscopic and surgical gastrostomy in patients with tumours of the head and neck or oesophagus. Br J Radiol (2002) 0.89
Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer (1990) 0.88
Hayflick's hypothesis: an approach to in vivo testing. Fed Proc (1975) 0.87
Somatostatin (somatostatinlike) immunoreactive cells in the human inner ear. Arch Otolaryngol Head Neck Surg (1986) 0.85
No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy. Eur J Cancer (1998) 0.85
[Predictive significance of reflex otalgia in local radical radiotherapy of oropharyngeal carcinomas]. Strahlenther Onkol (1998) 0.85
Criteria for assessment of functional impairment in patients with cirrhosis of the liver. Eur J Clin Invest (1973) 0.84
Visualization of the thymus by substance P receptor scintigraphy in man. Eur J Nucl Med (1996) 0.84
Carcinoma of the oropharynx: local failure as the decisive parameter for distant metastases and survival. Strahlenther Onkol (2000) 0.83
Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy. Int J Cancer (1993) 0.83
Introduction of a novel dose saving acquisition mode for the PortalVision aS500 EPID to facilitate on-line patient setup verification. Med Phys (2004) 0.83
Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets. J Clin Endocrinol Metab (1998) 0.82
Immunohistochemical characterization of the human endolymphatic sac and its associated cell populations. Acta Otolaryngol (1992) 0.82
Extensive extramedullary hematopoiesis in a thyroid nodule. Mod Pathol (1996) 0.82
Growth vs. DNA strand breaks in Hodgkin's disease: impaired proliferative ability of Hodgkin and Reed-Sternberg cells. Int J Cancer (1996) 0.81
Long-term evolution of renal function in patients with ovarian cancer after whole abdominal irradiation with or without preceding cisplatin. Ann Oncol (1999) 0.79
Secretory immunoglobulin A in the human endolymphatic sac. An immunohistochemical study. ORL J Otorhinolaryngol Relat Spec (1984) 0.79
[Metabolism, proliferation and phagocytic activity of free cells in the peritoneal cavity of the mouse after injection of polystyrene particles]. Z Zellforsch Mikrosk Anat (1969) 0.79
[Malacoplakia of the urinary bladder: histological, cytological and electron microscopic studies]. Urol Int (1969) 0.78
Kinetic studies on glial, Schwann and capsular cells labelled with [3H] thymidine in cerebrospinal tissue of young mice. J Neurol Sci (1975) 0.78
Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy. Strahlenther Onkol (2013) 0.78
Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys (2000) 0.77
Genetically determined disproportion between primary and secondary tetanus antitoxin responses and proliferative reactions in lymph nodes regional to the site of antigen injection: C57L/J compared with haired and hairless HRS/J mice. J Reticuloendothel Soc (1981) 0.77
Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. Breast Cancer Res Treat (2000) 0.77
Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch A Pathol Anat Histopathol (1992) 0.76
[Cell migration and proliferation following subcutaneous injection of paraffin oil into mice]. Beitr Pathol Anat (1969) 0.76
Disparity between humoral antibody formation and proliferative reactions in lymph nodes: C57L/J vs. haired and hairless HRS/J mice. Adv Exp Med Biol (1982) 0.76
Germinal center kinetics in lymph nodes of primed mice stimulated with complexed as opposed to free antigen. Immunol Lett (1989) 0.76
[Radiotherapy with rectangular fields compared to conformal fields. Fewer clinical failures in high-risk prostate cancer patients]. Strahlenther Onkol (2013) 0.75
Perioperative angiogenesis and outcome in premenopausal women with breast cancer. Lancet (1998) 0.75
Selective damage to erythroblasts by 55-Fe. Blood (1975) 0.75
[Renal manifestations of sarcoidosis]. Schweiz Med Wochenschr (1988) 0.75
[In-vivo staining of vagus fibers during vagotomy]. Schweiz Med Wochenschr (1970) 0.75
[Late damages after diagnostic use of thorotrast: intestinal stenosis after salpingography]. Schweiz Med Wochenschr (1970) 0.75
[Biopsies and serological investigations of the enteropathy in Duhring's dermatitis herpetiformis]. Dermatologica (1971) 0.75
[Preoperative vital staining of vagus fibers]. Dtsch Med Wochenschr (1972) 0.75
[Acute upper gastrointestinal hemorrhage in a 63-year-old alcoholic]. Schweiz Rundsch Med Prax (1993) 0.75
[Temporal arteritis or giant cell arteritis]. Schweiz Med Wochenschr (1969) 0.75
[Hemangio-endothelioma of the liver (case report) (author's transl)]. Z Kinderchir (1982) 0.75
[Intravascular uterine leiomyomatosis]. Schweiz Med Wochenschr (1979) 0.75
[Modification of proliferation and specific cell functions of neoplastic cells in vitro]. Schweiz Med Wochenschr (1972) 0.75
Functional morphology of the human endolymphatic sac. A review. ORL J Otorhinolaryngol Relat Spec (1992) 0.75
[Small bowel lesions in dermatitis herpetiformis]. Ther Umsch (1972) 0.75
[Ischemic injury to the small intestine]. Helv Chir Acta (1970) 0.75
Proliferation and specific function of neoplastic mast cells in culture. Effects of amino acid deprivation. Exp Cell Res (1971) 0.75
[Malignant bone tumors in childhood]. Schweiz Rundsch Med Prax (1970) 0.75
[Ischemic colitis]. Schweiz Med Wochenschr (1971) 0.75
[Ischemic lesions of the small intestine]. Bruns Beitr Klin Chir (1971) 0.75
[Megalocytic interstitial nephritis. A contribution to the differential diagnosis of the large insufficient kidney]. Schweiz Med Wochenschr (1981) 0.75
[Nongangrenous ischemic colitis: clinical course and radiologic diagnosis]. Fortschr Geb Rontgenstr Nuklearmed (1971) 0.75
[Behavior of mouse spleen germinal center cells after secondary stimulation with tetanus toxoid injected into the footpads. Radiographic studies with thymidine-3H]. Virchows Arch B Cell Pathol (1969) 0.75
Survival of chromium-51-labeled autologous and homologous erythrocytes in goats. Am J Vet Res (1975) 0.75
[Intracytoplasmic inclusions in the liver in myoclonus epilepsy]. Zentralbl Allg Pathol (1970) 0.75
[Congenital liver fibrosis]. Helv Paediatr Acta (1969) 0.75
[Peroperative vital staining of the fibers of the vagus nerve]. Minerva Chir (1973) 0.75
Proceedings: Early and late effects of 55Fe cytocide. Br J Cancer (1975) 0.75
[Foam cells in an-alpha1-lipoproteinemia]. Virchows Arch A Pathol Pathol Anat (1968) 0.75
[Results of pathologic-anatomical studies in patients with primary vascular pulmonary hypertension]. Schweiz Med Wochenschr (1970) 0.75
[Cell kinetic basis of whole body irradiation syndrome. (Pathology of radiation injuries)]. Strahlenschutz Forsch Prax (1971) 0.75
[Acquired cystic renal changes--a clinically relevant problem in long-term dialysis]. Schweiz Med Wochenschr (1987) 0.75
[Peroperative vital staining of the fibers of the vagus nerve]. Minerva Med (1973) 0.75
Survival of labelled and non-labelled platelets in the lethally irradiated dog; an evaluation of the 51-chromium method. Helv Med Acta (1970) 0.75
Simultaneous optimization of photons and electrons for mixed beam radiotherapy. Phys Med Biol (2017) 0.75
[Control of completeness of vagotomy following peroperative vital staining of vagus fibers]. Schweiz Med Wochenschr (1971) 0.75
[Functional morphology of the intestinal immune system]. Z Gastroenterol Verh (1978) 0.75
Case report 143. Multiple hereditary osteocartilaginous exostoses affecting right femur with an overlying giant cystic bursa (exostosis bursata). Skeletal Radiol (1981) 0.75
[Atypical infarction and necrosis of the intestine in underlying infectious disease]. Schweiz Med Wochenschr (1971) 0.75
Morphological changes in the jejunal remnant 4 years after extensive small bowel resection in early childhood. Pathol Microbiol (Basel) (1969) 0.75
[Febrile status, shift to the left and lymphopenia in systemic lupus erythematosus]. Schweiz Rundsch Med Prax (1994) 0.75
[Chronic defibrination syndrome and thrombocytopenia in splenic hamartoma (splenoma)]. Schweiz Med Wochenschr (1982) 0.75